Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Materials and methods for treatment of hemoglobinopathies

Materials and methods for treatment of hemoglobinopathies

US Patent 11268077 · Granted Mar 8, 2022

Estimated economic value: $375,122,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Materials and methods for treatment of hemoglobinopathies2025
Methods for therapeutic administration of messenger ribonucleic acid drugs2025
CRISPR-CAS9 modified CD34+ human hematopoietic stem and progenitor cells and use2024
Terminally modified RNA2024
Signal-sensor polynucleotides for the alteration of cellular phenotypes2023
Long-lived polynucleotide molecules2023
Methods for therapeutic administration of messenger ribonucleic acid drugs2023
Materials and methods for treatment of hemoglobinopathies2023
Compositions comprising synthetic polynucleotides encoding CRISPR related protei2021
Terminally Modified RNA2021
Methods for therapeutic administration of messenger ribonucleic acid drugs2020
Modified Polynucleotides for the production of biologics and proteins associated2020